{"id":990,"date":"2026-06-20T13:01:34","date_gmt":"2026-06-20T13:01:34","guid":{"rendered":"https:\/\/arora297consultancy.com\/blog\/post-approval-compliance-essentials-for-north-american-market-access-us-fda-health-canada\/"},"modified":"2026-06-20T13:01:34","modified_gmt":"2026-06-20T13:01:34","slug":"post-approval-compliance-essentials-for-north-american-market-access-us-fda-health-canada","status":"publish","type":"post","link":"https:\/\/arora297consultancy.com\/blog\/post-approval-compliance-essentials-for-north-american-market-access-us-fda-health-canada\/","title":{"rendered":"Post-Approval Compliance Essentials for North American Market Access (US FDA + Health Canada)"},"content":{"rendered":"

Post-approval compliance is not a one-time checkbox; it\u2019s the backbone of sustained North American market access. If your compliance program misses critical elements like FDA postmarket requirements or Health Canada reporting, your product\u2019s future in these markets is at risk. This post breaks down what your program must include to keep your products compliant and competitive\u2014and how Arora 297 Consultancy<\/a> can build and maintain these systems for you. Book a 30-minute consultation to assess your readiness and get a clear action plan tailored to your needs.<\/p>\n

Key Elements of Post-Approval Compliance<\/h2>\n

Ensuring your product remains compliant after approval is crucial. This involves several key elements that must be integrated into your compliance strategy.<\/p>\n

Pharmacovigilance and Device Vigilance<\/h3>\n

Monitoring the safety of your products is essential. Pharmacovigilance and device vigilance play a vital role in identifying and assessing adverse effects.<\/p>\n